Fischer John P, Wes Ari M, Nelson Jonas A, Basta Marten, Rohrbach Jeffrey I, Wu Liza C, Serletti Joseph M, Kovach Stephen J
Division of Plastic Surgery, Perelman School of Medicine at the Hospital of the University of Pennsylvania, Philadelphia, PA.
Division of Plastic Surgery, Perelman School of Medicine at the Hospital of the University of Pennsylvania, Philadelphia, PA.
J Am Coll Surg. 2014 Aug;219(2):303-12. doi: 10.1016/j.jamcollsurg.2014.02.028. Epub 2014 Apr 8.
Choosing a breast reconstructive modality after mastectomy is an important step in the reconstructive process. The authors hypothesized that autologous tissue is associated with a greater success rate and cost efficacy over time, relative to implant reconstruction.
A retrospective review was performed of patients undergoing free tissue (FF) transfer and expander implant (E/I) reconstruction between 2005 and 2011. Variables evaluated included comorbidities, surgical timing, complications, overall outcomes, unplanned reoperations, and costs. A propensity-matching technique was used to account for the nonrandomized selection of modality.
A total of 310 propensity-matched patients underwent 499 reconstructions. No statistically significant differences in preoperative variables were noted between propensity-matched cohorts. Operative characteristics were similar between FF and E/I reconstructions. The E/I reconstruction was associated with a significantly higher rate of reconstructive failure (5.6% vs 1.2%, p < 0.001). Expander implant reconstructions were associated with higher rates of seroma (p = 0.009) and lower rates of medical complications (p = 0.02), but overall significantly higher rates of unplanned operations (15.5% vs 5.8%, p = 0.002). The total cost of reconstruction did not differ significantly between groups ($23,120.49 ± $6,969.56 vs $22,739.91 ± $9,727.79, p = 0.060), but E/I reconstruction was associated with higher total cost for secondary procedures ($10,157.89 ± $8,741.77 vs $3,200.71 ± $4,780.64, p < 0.0001) and a higher cost of unplanned revisions over time (p < 0.05).
Our matched outcomes analysis does demonstrate a higher overall, 2-year success rate using FF reconstruction and a significantly lower rate of unplanned surgical revisions and cost. Although autologous reconstruction is not ideal for every patient, these findings can be used to enhance preoperative discussions when choosing a reconstructive modality.
乳房切除术后选择乳房重建方式是重建过程中的重要一步。作者推测,随着时间推移,相对于植入物重建,自体组织重建具有更高的成功率和成本效益。
对2005年至2011年间接受游离组织(FF)移植和扩张器植入物(E/I)重建的患者进行回顾性研究。评估的变量包括合并症、手术时机、并发症、总体结果、计划外再次手术和成本。采用倾向匹配技术来解释重建方式的非随机选择。
共有310例倾向匹配患者接受了499次重建手术。倾向匹配队列之间术前变量无统计学显著差异。FF和E/I重建的手术特征相似。E/I重建的重建失败率显著更高(5.6%对1.2%,p<0.001)。扩张器植入物重建的血清肿发生率更高(p=0.009),医疗并发症发生率更低(p=0.02),但总体计划外手术率显著更高(15.5%对5.8%,p=0.002)。两组之间重建总成本无显著差异(23,120.49美元±6,969.56美元对22,739.91美元±9,727.79美元,p=0.060),但E/I重建的二次手术总成本更高(10,157.89美元±8,741.77美元对3,200.71美元±4,780.64美元,p<0.0001),且随着时间推移计划外翻修成本更高(p<0.05)。
我们的匹配结果分析确实表明,使用FF重建的总体2年成功率更高,计划外手术翻修率和成本显著更低。虽然自体组织重建并非适用于每一位患者,但这些发现可用于在选择重建方式时加强术前讨论。